The Metabolism and Cancer Group, led by Dr. Javier A. Menéndez (ICO), is looking for a highly-motivated candidate to apply for the call for 4-year pre-doctoral contracts to join the Research line: “Post-translational modifications (PTM) of PD-L1 in cancer immunotherapy: Development of PD-L1 PTM-based therapeutics and pharmacodiagnostic tools (PI22/00297)” funded by the Instituto de Salud Carlos III (ISCIII) under the supervision of Dr. Elisabet Cuyàs.